Rooting Out Health Care Fraud: Tales from the Front Line

March 9, 2018: Health Policy and Bioethics Consortium
12:30 - 2 p.m.

By some measures, as much as 5% of health care spending can be linked to fraud, and dangerous practices from for-profit medical product companies have led to widespread negative health outcomes. Health care providers and others directly involved in the health care marketplace are often in an optimal position to recognize problematic business practices. How do we optimize responsible whistleblowing and promote an ethical culture within science, medicine, and business?


Pieter Cohen, MD
Associate Professor of Medicine
Cambridge Health Alliance and
Harvard Medical School 

Joan Gallagher
Former Sales Representative

This event is free and open to the public, but registration is required. 

The Health Policy and Bioethics Consortia is a monthly series that convenes two international experts from different fields or vantage points to discuss how biomedical innovation and health care delivery are affected by various ethical norms, laws, and regulations. They are organized by the Center for Bioethics at Harvard Medical School and the Program On Regulation, Therapeutics, And Law (PORTAL) at Brigham and Women's Hospital, in collaboration with the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School. Support provided by the Oswald DeN. Cammann Fund at Harvard University.


Health Policy and Bioethics